GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
12.45
-0.73 (-5.54%)
Oct 10, 2025, 2:11 PM EDT - Market open
GH Research Market Cap
GH Research has a market cap or net worth of $772.27 million as of October 10, 2025. Its market cap has increased by 112.35% in one year.
Market Cap
772.27M
Enterprise Value
467.33M
1-Year Change
112.35%
Ranking
Category
Stock Price
$12.45
Market Cap Chart
Since the IPO on June 25, 2021, GH Research's market cap has decreased from $808.33M to $772.27M, a decrease of -4.46%. That is a compound annual growth rate of -1.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 816.93M | 124.31% |
| Dec 31, 2024 | 364.20M | 20.71% |
| Dec 29, 2023 | 301.72M | -40.33% |
| Dec 30, 2022 | 505.64M | -58.34% |
| Dec 31, 2021 | 1.21B | 50.14% |
| Jun 25, 2021 | 808.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 759.23B |
| Johnson & Johnson | 456.84B |
| AbbVie | 408.50B |
| UnitedHealth Group | 335.03B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 265.74B |
| Novartis AG | 257.26B |
| Abbott Laboratories | 233.69B |